NG Biotech has obtained the Rapid Diagnostic Orientation Test (TROD) label for its NG-Test® IgG-IgM COVID-19 serological test following the ministerial decree of the 11th of July.
With this TROD status, private doctors and pharmacists can now use this rapid serological test for the detection of antibodies (IgG-IgM) against SARS-CoV-2.